Guidelines for designing, configuring, and implementing relevant accounting policies for a pharmaceutical entity

The pharmaceutical sector represents a major economic and social area of interest, with unique activities that require a tailored design of accounting policies. This paper aims to analyze the main aspects of accounting treatments and applicable regulations in this field, as well as their impact on the financial performance of an entity in the pharmaceutical retail sector. Within the specialized context of the pharmaceutical industry—characterized by strict regulations, rapid technological developments, and the complexity of research and development activities—accounting policies are required to accurately reflect economic reality, particularly concerning inventory valuation, revenue recognition, depreciation of fixed assets, and accounting for licenses and patents.